grantGrants.gov

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Organization National Institutes of HealthPosted 15 Oct 2024Deadline 14 Oct 2026
HHS-NIH1193.394synopsis
Sign up free to applyFree account · Full description · Apply link · All opportunity types

Full Description

Opportunity Number: PAR-25-074 Document Type: synopsis CFDA Numbers: 93.394

Read the full description

Sign up freeFree account · No credit card required
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) — National Institutes of Health | Dev Procure